Exoskeleton Market 2026 - a USD 3.5 Billion Revenue Opportunity : Parker Hannifin, Rex Bionics, Hocoma AG, Ekso Bionics, Hyundai Motor Company, Lockheed Martin
Rising healthcare spending for geriatric population will boost the exoskeleton market demand. For instance, in 2017, the U.S. spent around 18% of GDP in healthcare serving around 58 million disabled and elderly people. Growing penetration of patients suffering from physical disabilities will further augment the exoskeleton market till 2026. According to the National Spinal Cord Injury Statistical Center, in 2018, around 288,000 people were reported cases for spinal cord injuries, positively influencing the exoskeleton market share over the projected timeframe.
View full press release